vs
Better Home & Finance Holding Co（BETR）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Better Home & Finance Holding Co的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍（$44.3M vs $35.5M），RECURSION PHARMACEUTICALS, INC.净利率更高（-304.2% vs -3349.0%，领先3044.7%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 77.4%），RECURSION PHARMACEUTICALS, INC.自由现金流更多（$-47.3M vs $-167.8M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 41.1%）
巴贾吉金融有限公司是印度一家可吸收存款的非银行金融机构，总部位于普纳。截至2025年9月，该公司拥有1.1064亿客户，管理资产规模达46225亿卢比，约合550亿美元，是印度知名的非银行金融服务商。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
BETR vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $44.3M | $35.5M |
| 净利润 | $-39.9M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -3376.8% | -304.8% |
| 净利率 | -3349.0% | -304.2% |
| 营收同比 | 77.4% | 681.7% |
| 净利润同比 | 32.6% | 39.6% |
| 每股收益（稀释后） | $-2.52 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $44.3M | $35.5M | ||
| Q3 25 | $43.9M | $5.2M | ||
| Q2 25 | $44.1M | $19.2M | ||
| Q1 25 | $32.6M | $14.7M | ||
| Q4 24 | $25.0M | $4.5M | ||
| Q3 24 | $29.0M | $26.1M | ||
| Q2 24 | $32.3M | $14.4M | ||
| Q1 24 | $22.3M | $13.8M |
| Q4 25 | $-39.9M | $-108.1M | ||
| Q3 25 | $-39.1M | $-162.3M | ||
| Q2 25 | $-36.3M | $-171.9M | ||
| Q1 25 | $-50.6M | $-202.5M | ||
| Q4 24 | $-59.2M | $-178.9M | ||
| Q3 24 | $-54.2M | $-95.8M | ||
| Q2 24 | $-41.4M | $-97.5M | ||
| Q1 24 | $-51.5M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -3376.8% | -304.8% | ||
| Q3 25 | -88.9% | -3327.6% | ||
| Q2 25 | -81.9% | -916.8% | ||
| Q1 25 | -154.9% | -1297.9% | ||
| Q4 24 | -1428.3% | -4042.4% | ||
| Q3 24 | -186.5% | -377.1% | ||
| Q2 24 | -127.6% | -697.4% | ||
| Q1 24 | -230.8% | -698.4% |
| Q4 25 | -3349.0% | -304.2% | ||
| Q3 25 | -89.2% | -3135.3% | ||
| Q2 25 | -82.2% | -894.2% | ||
| Q1 25 | -155.3% | -1373.3% | ||
| Q4 24 | -1437.5% | -3935.5% | ||
| Q3 24 | -187.0% | -367.5% | ||
| Q2 24 | -128.2% | -676.6% | ||
| Q1 24 | -231.4% | -662.4% |
| Q4 25 | $-2.52 | $-0.17 | ||
| Q3 25 | $-2.56 | $-0.36 | ||
| Q2 25 | $-2.39 | $-0.41 | ||
| Q1 25 | $-3.33 | $-0.50 | ||
| Q4 24 | $-3.92 | $-0.56 | ||
| Q3 24 | $-3.58 | $-0.34 | ||
| Q2 24 | $-2.74 | $-0.40 | ||
| Q1 24 | $-3.41 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $203.4M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $37.2M | $1.1B |
| 总资产 | $1.5B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $203.4M | $743.3M | ||
| Q3 25 | $205.8M | $659.8M | ||
| Q2 25 | $221.5M | $525.1M | ||
| Q1 25 | $228.0M | $500.5M | ||
| Q4 24 | $264.9M | $594.4M | ||
| Q3 24 | $262.1M | $427.6M | ||
| Q2 24 | $378.8M | $474.3M | ||
| Q1 24 | $482.6M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $37.2M | $1.1B | ||
| Q3 25 | $41.9M | $1.0B | ||
| Q2 25 | $76.6M | $919.1M | ||
| Q1 25 | $-102.1M | $933.9M | ||
| Q4 24 | $-58.2M | $1.0B | ||
| Q3 24 | $388.0K | $524.6M | ||
| Q2 24 | $44.9M | $584.4M | ||
| Q1 24 | $76.3M | $401.2M |
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $913.1M | $1.4B | ||
| Q3 24 | $845.2M | $726.5M | ||
| Q2 24 | $957.9M | $775.9M | ||
| Q1 24 | $841.6M | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-166.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-167.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | -378.6% | -133.1% |
| 资本支出强度资本支出/营收 | 2.7% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-277.9M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $-166.6M | $-46.1M | ||
| Q3 25 | $4.2M | $-117.4M | ||
| Q2 25 | $-56.3M | $-76.4M | ||
| Q1 25 | $-57.2M | $-132.0M | ||
| Q4 24 | $-380.0M | $-115.4M | ||
| Q3 24 | $-10.6M | $-59.2M | ||
| Q2 24 | $-220.6M | $-82.2M | ||
| Q1 24 | $-42.8M | $-102.3M |
| Q4 25 | $-167.8M | $-47.3M | ||
| Q3 25 | $4.0M | $-117.6M | ||
| Q2 25 | $-56.7M | $-79.6M | ||
| Q1 25 | $-57.4M | $-133.8M | ||
| Q4 24 | $-383.4M | $-116.7M | ||
| Q3 24 | $-11.7M | $-63.8M | ||
| Q2 24 | $-221.8M | $-83.4M | ||
| Q1 24 | $-43.3M | $-109.0M |
| Q4 25 | -378.6% | -133.1% | ||
| Q3 25 | 9.1% | -2272.5% | ||
| Q2 25 | -128.5% | -413.9% | ||
| Q1 25 | -176.3% | -907.4% | ||
| Q4 24 | -1534.6% | -2567.7% | ||
| Q3 24 | -40.5% | -244.6% | ||
| Q2 24 | -687.6% | -578.5% | ||
| Q1 24 | -194.5% | -789.9% |
| Q4 25 | 2.7% | 3.5% | ||
| Q3 25 | 0.5% | 4.7% | ||
| Q2 25 | 0.9% | 16.4% | ||
| Q1 25 | 0.6% | 12.4% | ||
| Q4 24 | 13.6% | 28.6% | ||
| Q3 24 | 4.1% | 17.5% | ||
| Q2 24 | 3.9% | 8.2% | ||
| Q1 24 | 2.1% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
